logo

Kiniksa Pharmaceuticals, Ltd. (KNSA)



Trade KNSA now with
  Date
  Headline
11/1/2018 8:16:03 AM Kiniksa Pharma Q3 Net Loss $24.4 Mln Vs Net Loss Of $16.0 Mln Last Year
9/17/2018 6:38:51 AM Wedbush Reiterates Kiniksa Pharmaceuticals, Ltd. (KNSA) At Outperform With $31 Price Target
9/11/2018 9:50:12 AM Wedbush Reiterates Kiniksa Pharmaceuticals, Ltd. (KNSA) At Outperform With $31 Price Target
8/7/2018 8:03:19 AM Wedbush Is Raising Kiniksa Pharmaceuticals, Ltd. (KNSA) FY19 Estimate To -3.08 From -3.60
8/7/2018 8:03:05 AM Wedbush Is Increasing Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 19 Estimate To -0.87 From -1.01
8/7/2018 8:02:50 AM Wedbush Is Raising Kiniksa Pharmaceuticals, Ltd. (KNSA) Q3 19 Estimate To -0.80 From -0.93
8/7/2018 8:02:34 AM Wedbush Is Raising Kiniksa Pharmaceuticals, Ltd. (KNSA) Q2 19 Estimate To -0.74 From -0.86
8/7/2018 8:02:21 AM Wedbush Is Increasing Kiniksa Pharmaceuticals, Ltd. (KNSA) Q1 19 Estimate To -0.68 From -0.79
8/7/2018 8:02:00 AM Wedbush Is Cutting Kiniksa Pharmaceuticals, Ltd. (KNSA) FY18 Estimate To -2.71 From -2.43
8/7/2018 8:01:47 AM Wedbush Is Increasing Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 18 Estimate To -0.80 From -0.94
8/7/2018 8:01:32 AM Wedbush Is Increasing Kiniksa Pharmaceuticals, Ltd. (KNSA) Q3 18 Estimate To -0.45 From -0.52
8/7/2018 8:01:09 AM Wedbush Reiterates Kiniksa Pharmaceuticals, Ltd. (KNSA) At Outperform With $32 Price Target
8/6/2018 7:36:20 AM Kiniksa Pharma Q2 Net Loss Of $20.3 Mln Vs Loss Of $11.2 Mln Last Year
6/25/2018 7:05:11 AM Kiniksa Announces Exercise Of Underwriters’ Option To Purchase Additional Shares
6/18/2018 6:57:52 AM Wedbush Starts Kiniksa Pharmaceuticals, Ltd. (KNSA) At Outperform With $31.00 Price Target